Patrik Brundin
39 results.
By: Patrik Brundin, M.D., Ph.D. Director of Van Andel Research Institute’s Center for Neurodegenerative Science, chairman of The Cure Parkinson’s Trust’s Linked…
New data published today shows drug preserves critical brain function in laboratory models of Parkinson’s GRAND RAPIDS, Mich. (Dec. 7, 2016)—A new investigational drug originally…
GRAND RAPIDS, Mich. (Aug. 8, 2016)—They’re two of the biggest mysteries in Parkinson’s disease research—where does the disease start? And how can it be stopped…
GRAND RAPIDS, Mich. (July 27, 2016)—Clues that point toward new risk mechanisms for developing Parkinson’s disease are hiding in some unusual spots, according to
Note: To read the commentary published in the Journal of Parkinson's Disease click here. Investigators will focus on safety for long-term use in non-cancer…
By Patrik Brundin, M.D., Ph.D. Director, Center for Neurodegenerative Science The time has come to shift the paradigm on Parkinson’s disease. Never before have we…
GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus…
GRAND RAPIDS, Mich. (June 2, 2015)—Van Andel Research Institute and the Netherlands-based ParkinsonNet today took the first steps toward broadening an initiative that will benefit…